American Society of Clinical Oncology

SHERPA: White

People

  1. Haque
    Haque
  2. Pfister
    Pfister
  3. Sherman
    Sherman
  4. Xiao
    Xiao
  5. Baxi
    Baxi
  6. Ho
    Ho
  7. Ng
    Ng
  8. Fagin
    Fagin
  9. Gelblum
    Gelblum
  10. Ghossein
    Ghossein

Groups

  1. Department of Medicine (4)
  2. Head and Neck Service (4)
  3. Neuroradiology Service (4)
  4. Radiology, Department of (4)
  5. Solid Tumor Oncology Division (4)
  6. Genitourinary Oncology Service (3)
  7. Thoracic Oncology (2)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  9. Biostatistics Service (1)
  10. Center for Hematologic Malignancies (1)
Search Within
  1. "Neuroradiology Service"
  2. "Stephanie Smith-Marrone"
Formats
  1. Meeting Abstract (4)
Groups
  1. Department of Medicine (4)
  2. Head and Neck Service (4)
  3. Neuroradiology Service (4)
  4. Radiology, Department of (4)
  5. Solid Tumor Oncology Division (4)
  6. Genitourinary Oncology Service (3)

More Groups

People
  1. David Pfister (4)
  2. Eric Sherman (4)
  3. Matthew Fury (4)
  4. Sofia Haque (4)
  5. Stephanie Smith-Marrone (4)
  6. Han Xiao (3)

More People

Years
  1. 2014 (1)
  2. 2013 (1)
  3. 2012 (1)
  4. 2011 (1)
Publications
  1. Journal of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC
    Meeting Abstract

    Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Smith-Marrone, S.; Ho, A. L.; Sima, C. S.; Nwankwo, O. G.; Haque, S.; Katabi, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus/sorafenib in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Korte, S. H.; Smith-Marrone, S.; Xiao, H.; Ghossein, R. A.; Fagin, J. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save